Background: Patients with immunoglobulin A (IgA) nephropathy may progress to end-stage renal disease (ESRD) within 10 to 20 years after renal biopsy. We evaluated factors associated with long-term renal survival by using a novel simplified histological classification.
P
rimary immunoglobulin A (IgA) nephropathy occurs worldwide and is characterized by recurrent episodes of macroscopic hematuria (which usually arise during upper respiratory tract infections) or asymptomatic persistent microscopic hematuria with or without proteinuria. Few epidemiological studies examined the incidence of primary IgA nephropathy in various populations around the world. [1] [2] [3] [4] National renal biopsy registries showed that IgA nephropathy is the most common form of primary glomerulonephritis worldwide (30% to 40% of all biopsyproven primary glomerulonephritis), [5] [6] [7] [8] [9] [10] [11] with an incidence ranging from 8.4 to 11.1 cases per million population in Italy 5,10-11 compared with 5.4 to 12.4 per million population in central and eastern Kentucky (United States) 12 and 26 patients per million population in Cotes d'Armor (France). 13 Although initially believed to represent a benign condition, 14 IgA nephropathy is now recognized as a cause of end-stage renal disease (ESRD) in a substantial proportion of patients within 10 to 20 years from its apparent onset. 2 The clinical course is extremely variable and ranges from asymptomatic microscopic hematuria to rapidly progressive renal failure.
Certain renal lesions were associated in some studies with poorer renal prognosis, and several morphological classifications were adopted. The use of different types of classifications is responsible in part for existing controversies in the assessment of rates of progression to ESRD and other renal outcomes. In general, histological grading mainly was based on the presence of cellular proliferation, glomerulosclerosis, crescents, and tubulointerstitial damage. Despite assessment and validation in a cohort of only 20 patients, the most widely adopted classification was that developed by Lee et al, 15 which includes 5 histological grades of disease. This classification was revised subsequently by Haas, 16 who suggested that the classification of Lee et al 15 underscored tubulointerstitial damage. Even the revised classification of Haas 16 was validated in a single cohort of only 109 patients.
Single and multicenter biopsy data available from large cohorts of patients with IgA nephropathy allow for more sophisticated testing of the predictive value and validity of the classification of IgA nephropathy for renal outcomes. We updated and simplified the histological classification 17 of IgA nephropathy based on descriptive criteria of renal lesions made by Churg et al 18 and accepted by the World Health Organization and scored renal biopsy specimens of our patients. In this retrospective study, we assembled a large cohort of patients with IgA nephropathy and evaluated factors recorded at the time of renal biopsy and associated with long-term renal survival, then validated this novel simpler classification in predicting renal outcomes.
METHODS

Renal Biopsy
From January 1971 to December 2004, information for 2,710 renal biopsies of native kidneys performed and/or processed in our unit were collected. In 796 of these (29.4%), IgA nephropathy was diagnosed, and a cohort of 437 patients (296 men, 67.7%; 141 women, 32.3%) followed up for more than 1 year in our single center until December 2006 were included in the study population. In our clinical policy, main reasons for performing a renal biopsy were asymptomatic urinary abnormalities (persistent microscopic hematuria and mild to moderate proteinuria), recurrent episodes of macroscopic hematuria, nephrotic syndrome, acute renal failure, or chronic renal insufficiency of unknown origin without severe alterations shown by means of ultrasound imaging. Biopsies were performed at least 30 days after episodes of macroscopic hematuria. The diagnosis of IgA nephropathy was made by the detection of mesangial deposits staining predominantly for IgA with immunofluorescence studies. Patients with systemic lupus erythematosus, HenochSchönlein purpura, or chronic liver diseases were excluded. All biopsy specimens were reviewed by 2 separate pathologists masked to patient outcomes and clinical characteristics. Biopsy specimens were scored according to the morphological classification of Lee et al 15 and using our modified classification.
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To assess the severity of renal damage, we distinguish 3 grades (Gs): G1 (mild) includes patients with IgA nephropathy with minor or minimal lesions, G2 (moderate) includes patients with focal-segmental or diffuse proliferative glomerulonephritis, and G3 (severe) includes patients with sclerotic lesions in advanced chronic glomerulonephritis or ESRD. Mesangial hypercellularity was scored as follows: mild with more than 3 and 5 or fewer mesangial cells, and moderate-severe with more than 6 mesangial cells on average in at least 2 glomerular lobules. Sclerosis was defined as the obliteration of capillary loops caused by prevalent increase in matrix, capillary tuft adhesion to Bowman capsule, or both. Endocapillary proliferation was defined as obliteration of the capillary tuft by cells (endothelial, mesangial, or inflammatory cells). Biopsy specimens with normal glomeruli or glomeruli with only a mild increase in mesangial cellularity and no tubulointerstitial changes were assigned to grade G1. The presence of even only 1 glomerulus with segmentally sclerotic lesion excluded a case from being assigned to this grade. Biopsy specimens were assigned to grade G2 if 1 of the following signs was detected: moderate increase in mesangial cellularity (focal or diffuse), endocapillary proliferation, cellular crescents (up to 50% of glomeruli involved), segmental sclerosis, tubular atrophy, and interstitial fibrosis (up to one third of the cortical area). Biopsy specimens were assigned to grade G3 if cellular crescents were present in greater than 50% of glomeruli and/or fibrous crescents or global glomerulosclerosis were present in greater than one third of glomeruli and/or segmentally sclerotic lesions involved greater than 50% of glomeruli (ie, diffuse) and/or tubular atrophy and interstitial fibrosis involved greater than one third of cortical areas. Essential features of the 5-and 3-grade systems used for comparison are listed in Table 1 . Patients followed up for at least 1 year, with an average follow-up for the entire cohort of 9 years, were included in the study.
Study Factors and Definitions
Demographic, clinical, laboratory, and histological data were recorded in our database, including sex, age at the time of apparent onset of symptoms and at renal biopsy, and type of onset (microscopic or recurrent macroscopic hematuria). Mean arterial pressure, serum creatinine level, estimated creatinine clearance using the Cockcroft-Gault equation, and 24-hour urinary protein excretion were considered at the time of renal biopsy. No missing data were present and handled. Asymptomatic persistent microhematuria (Ͼ5,000 red blood cells/mL in urine) without episodes of macrohematuria sometimes was detected by chance as a result of screening for preemployment, sport activities, or blood donation. Usually microhematuria was accompanied by mild proteinuria (urinary protein excretion, 0.1 to 0.9 g/24 h), rarely by moderate (1.0 to 2.9 g/24 h) or severe proteinuria (Ն3.0 g/24 h). The number of recurrent episodes of macrohematuria was variable, usually occurred during upper respiratory tract infections, and persisted for less than 3 days; urine color was red or brown and blood casts were common. Mean arterial pressure of 107 mm Hg or greater was regarded as hypertension according to World Health Organization crite- Note: Lee's classification on left and 3-grade classification on right. Mesangial hypercellularity was scored as follows: mild (Ͼ3 and Յ5 mesangial cells), moderate to severe (Ն6 mesangial cells on the average) at least in 2 glomerular lobules. Sclerosis was defined as the obliteration of capillary loops due to prevalent increase in matrix or as capillary tuft adhesion to Bowman capsule or both. Endocapillary proliferation was defined as the obliteration of the capillary tuft by cells (endothelial, mesangial, or inflammatory cells).
ria. All exposure and outcome data were double-entered in a relational database. Data entry was checked by a third investigator at the time of data analysis.
Study Outcome
The study end point was progression of renal disease estimated on the basis of ESRD and evaluated as the need for regular dialysis treatment or renal transplantation. In our monocentric study, the same criteria were applied to all patients with a creatinine clearance less than 5 mL/min (Ͻ0.08 mL/s) and/or with uremic symptoms.
Regulatory Considerations
The study was performed according to recommendations outlined in the Declaration of Helsinki (IV Adaptation). Each patient who underwent renal biopsy in our institution was informed of the expected benefits and potential risks associated with the procedure and agreed to anonymous use of collected data for future descriptive or inferential statistical analyses, providing an informed consent.
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Statistical Analysis
Continuous data were analyzed descriptively using mean Ϯ SD or median and interquartile range, and categorical data were described as integers, frequencies, and percentages, as appropriate. Baseline characteristics of individuals affected by IgA nephropathy were compared using 1-way analysis of variance, Kruskal-Wallis test, unpaired Student t-test, and Mann-Whitney U test as appropriate for continuous data and chi-square statistic for categorical data. Univariate and multivariate analyses of renal survival were carried out based on the end point of ESRD or renal transplantation. Potential nonlinear effects of exposure factors were explored as appropriate and reported if identified. Cumulative renal survival and its 95% confidence interval (CI) from the time of renal biopsy was analyzed by means of Kaplan-Meier curves for censored data. Differences between groups were compared using log-rank test.
Univariate and multivariate analysis based on the Cox regression proportional hazard method was used to assess the relative risk of reaching the outcome of ESRD based on the influence of baseline prognostic factors (age, sex, presence of hematuria [micro or macro], presence of hypertension, serum creatinine level, urinary protein excretion, and the 3-17 and 5-grade 15 histological classification systems). Variables that could significantly predict ESRD on univariate analysis (P Ͻ 0.05 or clinical relevance) were used to construct a multivariate Cox model. The final model of adequate statistical power was constructed by means of backward and stepwise approaches to check for consistency, with covariates averaged at baseline. Finally, goodness of fit was tested. Risk estimates are presented as unadjusted and adjusted hazard ratios (HRs) and their 95% CIs, calculated by using an estimated regression coefficient and its SE in the Cox regression analysis. Wald test was used to establish the hierarchy of prognostic factors. All analyses were performed using SAS, version 8.1 (SAS Institute, Cary, NC), and SPSS for Windows, release 12.0 (SPSS Inc, North Sydney, Australia). P less than 0.05 is considered statistically significant.
RESULTS
Baseline demographic and clinical findings at the time of renal biopsy are listed in Table 2 . Mean age at renal biopsy was 31.0 Ϯ 11.4 years. Mean age at apparent onset of disease was 27.0 Ϯ 10.7 years. Average time from onset to biopsy was 4.0 Ϯ 5.7 years. Type of onset was macroscopic hematuria in 253 of 437 patients (57.9%) and persistent microhematuria in 184 of 437 patients (42.1%). Arterial hypertension was present in 165 of 437 patients (37.7%). At renal biopsy, median serum creatinine value was 1.0 mg/dL (interquartile range, 0.9 to 1.3 [88.4 mol/ L]; interquartile range, 79.6 to 114.9]), mean creatinine clearance was 92.2 Ϯ 29.9 mL/min (1.54 Ϯ 0.50 mL/s), median daily proteinuria value was protein of 0.70 g/24 h (interquartile range, 0.30 to 1.50), and mean arterial pressure was 97.8 Ϯ 10.2 mm Hg. At any time during the Note: Data expressed as mean Ϯ SD, median (interquartile range), and absolute and percent frequency.
To convert serum creatinine in mg/dL to mol/L, multiply by 88.4, creatinine clearance in mL/min to mL/s, multiply by 0.01667.
Abbreviations: ACE, angiotensin-converting enzyme; ARB, angiotensin receptor blocker.
*Indicated by the presence of hypertension or proteinuria with protein greater than 0.5 g/24 h. study observation period, hypertensive patients and those with proteinuria with protein greater than 0.5 g/24 h received angiotensin-converting enzyme inhibitors or angiotensin receptor blockers, and no patient was treated with steroids or cytotoxic drugs.
The distribution of histological lesions according to Lee's classification was as follows: grade I, 44 patients (10.1%); grade II, 150 patients (34.3%); grade III, 159 patients (36.4%); grade IV, 58 patients (13.2%); and grade V, 26 patients (6.0%). Baseline demographic and clinical findings according to the 5 different histological grades at the time of renal biopsy are listed in Table 3 . There was a significant difference among groups for age at renal biopsy (P Ͻ 0.0001), age at apparent onset (P Ͻ 0.0001), type of onset of disease (P Ͻ 0.001), proportion of patients with arterial hypertension (P Ͻ 0.0001), median values for serum creatinine and daily proteinuria, and mean creatinine clearance (P Ͻ 0.0001). According to our novel and simpler 3-grade classification, the distribution of histological lesions was as follows: 173 patients (39.6%) with mild renal damage (G1), 186 patients (42.6%) with moderate renal damage (G2), and 78 patients (17.8%) with severe renal damage (G3). Baseline demographic and clinical findings according to the 3 different histological grades at the time of renal biopsy are listed in Table 4 . There was a significant difference among groups for age at renal biopsy (P Ͻ 0.0001), age at apparent onset (P Ͻ 0.001), type of onset of disease (P Ͻ 0.002), proportion of patients with arterial hypertension (P Ͻ 0.0001), median values for serum creatinine and daily proteinuria, and mean creatinine clearance (P Ͻ 0.0001).
Renal Survival
During a mean follow-up of 107.6 Ϯ 63.2 months, 72 ESRD events occurred. The 5-, 10-, 15-, and 20-year renal survival rates in all patients from time of renal biopsy were 94.1% (patients at risk, 349), 82.1% (patients at risk, 152), 73.1% (patients at risk, 53), and 60.3% (patients at risk, 24), respectively. No patient died before ESRD during the study observation period. As shown in Fig 1A, the cumulative probability of ESRD was greater in patients with grades IV and V histological lesions compared with those with grades I, II, and III (log-rank test, chi-square 113.2; P Ͻ 0.0001) according to Lee's classification. Furthermore, the cumulative probability of ESRD was greater in patients with severe lesions (G3) than those with moderate (G2) and mild renal damage (G1) according to our 3-grade classification system (log-rank test, chi-square 179.7; P Ͻ 0.0001; Fig 1B) . The distribution of ESRD events in patients according to 5 and 3 categories of histological classification are listed in Table 5 . Unadjusted and adjusted HR estimates of the association between these different risk factors and ESRD are reported in 2 different models. In each analysis, 7 variables at the time of renal biopsy (age, sex, microhematuria at onset, arterial hypertension, serum creatinine [milligrams per deciliter], proteinuria [grams of protein per 24 hours], and the 5-[ Table 6 ] or 3-grade [ Table  7 ] systems of histological renal lesions) were included in the multivariate model. There was a strong association between risk of ESRD and presence of microhematuria at onset (adjusted HR, 2.05; 95% CI, 1.22 to 3.44; P ϭ 0.007; adjusted HR 2.18, 95% CI 1.30 to 3.65, P ϭ 0.003), but no association between the presence of arterial hypertension and risk of ESRD (adjusted HR, 1.64; 95% CI, 0.91 to 2.95; P ϭ 0.102; adjusted HR, 1.08; 95% CI, 0.60 to 1.93; P ϭ 0.802). In addition, risk of ESRD significantly increased for every 1.0 mg/dL (88.4 mol/L) increase in serum creatinine level (adjusted HR, 1.77; 95% CI, 1.26 to 2.48; P ϭ 0.001; adjusted HR, 1.50; 95% CI, 1.10 to 2.07; P ϭ 0.013) and for every 1.0-g/24 h increase in daily proteinuria (adjusted HR, 1.27; 95% CI, 1.07 to 1.50; P ϭ 0.006; adjusted HR, 1.28; 95% CI, 1.07 to 1.52; P ϭ 0.006).
Finally, with respect to grading of histological lesions on a continuous scale of risk assessment, for every 1-stage increase in degree of disease according to Lee's classification, there was a nearly 2-fold increase in risk of ESRD (adjusted HR, 1.74; 95% CI, 1.29 to 2.34; P Ͻ 0.0001); for every 1-stage increase in degree of disease according to our simple 3-grade classification system, there was a nearly 6-fold increase in risk of ESRD (adjusted HR, 5.95; 95% CI, 3.54 to 10.01; P Ͻ 0.0001). Adjusted estimates of renal survival by individual degree of histological lesion are shown in Fig 2. Of note, there was some overlap between survival in patients with grades IV and V disease when we used Lee's classification, but not when we used the new classification.
DISCUSSION
In this study, we tested the value of our novel simpler histological classification of IgA nephropathy in predicting renal outcomes. Baseline demographic and clinical findings of our cohort of 437 patients with IgA nephropathy followed up in a single center differed according to the use of the 5 or 3 histological grades at time of renal biopsy. The overall 20-year renal survival rate with ESRD as the end point was 60.3%. The probability of cumulative ESRD was greater in patients with grades IV and V histological lesions compared with those with grades I, II, and III according to Lee's classification. Furthermore, the probability of cumulative ESRD was greater in patients with severe lesions (G3) than those with moderate (G2) and mild (G1) lesions according to our 3-grade classification system. Significant predictors of ESRD risk were microscopic hematuria without episodes of macroscopic hematuria at onset of the disease, greater serum creatinine level, greater proteinuria, and histological grading. Risk of ESRD nearly doubled for every unit increase in histological grade according to Lee's classification on a continuous scale, whereas risk increased nearly 6-fold for every unit increase in the degree of disease according to our simpler 3-grade classification system. With a 3-level grading system, risk of ESRD appeared to be greater in patients with microscopic hematuria and proportionally increased for every 1.0 mg/dL (88.4 mol/L) greater baseline serum creatinine level (adjusted HR, 1.50; 95% CI, 1.10 to 2.07; P ϭ 0.013) and 1.0 g/24 h greater baseline urinary protein excretion (adjusted HR, 1.28; 95% CI, 1.07 to 1.52; P ϭ 0.006).
The simpler histological classification allowed the enrollment of a larger number of patients for each grade of renal lesion and permitted validation of our system on a large homogeneous IgA nephropathy population followed up over a long period in a single center. Univariate and multivariate statistical analysis indicated no overlap between different grades in our classification; however, we did not evaluate whether our new classification was more accurate compared with others reported in the literature.
The identification of clinical and histological factors at renal biopsy that affect disease progression in patients with IgA nephropathy has stimulated abundant research during the past 20 years. Considering the supposed benign nature and slow progression of the disease and relatively aggressive nature of proposed interventions (eg, steroids and other immunosuppressive regimens), it is important to understand which patients might or might not progress and benefit from these therapeutic interventions. Most studies from Europe, Asia, and Australia focused on 5-to 10-year follow-up [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] and reported renal survival rates ranged from 74% 32 to 94% 29 at 10 years. A substantially worse prognosis was reported in North American studies, with rates of 57% to 70% at 10 years from onset of disease or biopsy. 16, [37] [38] [39] Clearly, longer-term follow-up is important considering the very low proportion of events, even after 10 years of observation. However, only 6 studies looked at survival over a longer time frame of 20 years, with rates ranging from 50% to 83%. 21, 22, 24, 25, 29, 34 A critical and comparative appraisal of available studies of survival in IgA nephropathy cohorts is difficult for several reasons. First, there are inconsistencies in the definition of the beginning of the observation, which may be at the time of renal biopsy 16, 20, 28, 30, 32, 33, [35] [36] [37] [38] or apparent onset of disease. [21] [22] [23] [24] [25] [26] 29, 31, 34, 39 Second, different end points (including increased serum creatinine level, doubling of serum creatinine level, or ESRD, defined as the need for regular dialysis or renal transplantation) were used in the studies. Third, statistical analyses used several options, but were simple (typically univariate analysis without adjustment for potential confounders). Fourth, in general, few studies had a follow-up longer than 20 years, and there is extreme variability in histological lesions and renal function in the studied cohorts. Finally, the potential confounding by different diagnostic and therapeutic approaches was not considered in detail in analyses of multicentric databases, proven because studies enrolled cohorts of both treated and untreated patients and analyses did not account for this variable. Taken together, these aspects highlight the potential for misleading results in the presence of significant heterogeneity of disease and management patterns.
Review studies conducted to date by D'Amico 40,41 identified 3 levels of clinical and histological prediction of an adverse outcome in adult patients with IgA nephropathy according to significance by multivariate analysis (so-called "strong predictors"), univariate or multivariate analysis (so-called "moderate predictors"), and univariate analysis only (so-called "poor predictors"). The major contribution of this analysis focused on the importance of histological lesions and highlighted the need for consensus on adequate classification of the disease. Two main types of classification were suggested by Waldo in a special report on IgA nephropathy 42 : the "lumped" system like those of Lee et al, 15 Mina and Murphy, 43 and Haas, 16 and the "split" system like those of Kobayashi et al, 44 Andreoli and Bergstein, 45 Alamartine et al, 29 and Waldo et al. 46 The lumped systems are simple and easily applicable in multicenter studies, but their weakness is the lack of flexible interpretation. The split system gives a more detailed analysis of each lesion of the 4 major compartments (glomeruli, tubules, interstitium, and vessels), thus giving a global score. Although the study of single lesions in a biopsy specimen allows identification of specific markers of damage in comparing 2 or more renal biopsy specimens from the same patient, grading of progressive severity of histological lesions using our new lumped system triggers a good definition of risk progression using statistical analysis. This validation in a large cohort of patients with IgA nephropathy followed up over a long time suggests that this classification may be preferred with respect to that of Lee et al, 15 who enrolled only 20 patients. Our data are consistent with other data reported in the literature. Conflicting results for degree of hematuria, whether microscopic or macroscopic, lose their prognostic values at multivariate analysis in most studies. To the best of our knowledge, this study represents the largest analysis of survival of patients with IgA nephropathy in which a multivariate approach was adopted (Table 8) , with an appropriate model designed to adjust for potential confounders that may have biased previous reports. Our study also was based on a predefined study protocol with all analyses set a priori to avoid the potential for data dredging. Furthermore, we chose ESRD (need for dialysis or transplantation) as our predefined outcome of interest, which is more valid and informative in terms of doubling of serum creatinine level. This latter outcome may be misleading because many patients with IgA nephropathy start with moderate renal function impairment (serum creatinine levels up to 2.3 mg/dL [203.3 mol/L]) and remain in a steady state for several years. 47 The study has several limitations. We included in our survival analysis both treated and untreated patients, when, in particular, antihypertensive agents may have a role in retarding the progression of renal disease. Our choice was to not adjust for the potential confounding effect of antihypertensive drugs, particularly angiotensinconverting enzyme inhibitors, which were introduced in the 1990s and might have influenced the natural history of disease. We based our choice on the following considerations. Their use is now considered standard care, and the largest proportion of our patients received this treatment, with no significant differences among histologic grades; and we did not aim to ascertain the role of immunosuppressive and other treatments on the history of disease considering that this is the role of randomized controlled trials, rather than cohort designs. 48, 49 Although this is the largest cohort reported to date (n ϭ 437), the singlecenter nature of the report may affect its external validity. The only study with a similar sample size was that of Koyama et al 34 (n ϭ 448), which included a large proportion of pediatric patients. In that study, only 335 adult patients were evaluated by means of multivariate analysis for risk factors, and there was no subgroup analysis for assessment of this item as a potential effect modifier. In short, we attempted an analysis based on long-term follow-up of 20 years in association with use of multivariate analysis to address the potential limitations of available data. The population of interest was Caucasian, with different genetic characteristics from Asian patients.
In conclusion, IgA nephropathy is characterized by extreme variability in clinical course and slow progression to ESRD in more than 40% of patients in long-term follow-up. Microscopic hematuria, serum creatinine level, daily proteinuria, and severity of histological lesions were associated significantly with adverse outcomes. What is the usefulness of this information in clinical practice and particularly clinical research? Debate exists on the appropriateness of using immunosuppressive regimens in low-risk populations. The use of the new simple histological classification associated with clinical indicators that we identified may be considered for evaluating the risk of progressive renal damage 
